Guohai J. Shi
No. 270 Dong' An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 96 publications
Spatial and single-cell multi-omics reveal pro-angiogenic THY1⁺ fibroblast subtypes predicting prognosis in prostate cancer.
Journal: Translational oncology
Published: October 10, 2025
A Metastasis-competent CAF Subpopulation Defined by MFAP5⁺THY1⁺ Co-expression Drives Prostate Cancer Metastasis via EMT Activation.
Journal: Recent patents on anti-cancer drug discovery
Published: August 20, 2025
Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial Carcinoma.
Journal: JCO precision oncology
Published: July 25, 2025
Proteogenomic Analysis Identifies Clinically Relevant Subgroups of Collecting Duct Carcinoma.
Journal: Research (Washington, D.C.)
Published: June 04, 2025
Genomic landscape and molecular evolutionary trajectories of renal epithelioid angiomyolipoma and benign angiomyolipoma.
Journal: Neoplasia (New York, N.Y.)
Published: April 18, 2025
KBTBD11 loss promotes AKT hyperactivation and therapeutic vulnerability in prostate cancer.
Journal: Oncogene
Published: November 22, 2024
Integrated clinical and proteomic-based model for diagnostic and prognostic prediction in pRCC.
Journal: Journal of hematology & oncology
Published: October 28, 2024
Cuproptosis-related signature predicts prognosis and indicates tumor immune infiltration in bladder cancer.
Journal: Translational andrology and urology
Published: August 28, 2024
Lon protease 1-mediated metabolic reprogramming promotes the progression of prostate cancer.
Journal: Cell death & disease
Published: June 18, 2024
Integration Analysis of Single-Cell Multi-Omics Reveals Prostate Cancer Heterogeneity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 15, 2023
Last Updated: 09/26/2026